Inebilizumab reduces the risk of flares in IgG4-related disease
1. In this randomized controlled trial, inebilizumab, an anti-CD19 monoclonal antibody, reduced the risk of flares and increased the likelihood ...
1. In this randomized controlled trial, inebilizumab, an anti-CD19 monoclonal antibody, reduced the risk of flares and increased the likelihood ...
1. CDASI-A score at 12 weeks was significantly lower in dazukibart 600 mg versus placebo, suggesting reduced morbidity. 2. Treatment-related ...
Postpartum depression in relation to chronic diseases and multimorbidity in women’s mid-late life: a prospective cohort study of UK Biobank ...
1. The use of electrically heated mittens for 6 weeks was not associated with improved physical hand function in patients ...
1. Low muscle strength, obesity, and sarcopenic obesity were associated with a greater risk of incident symptomatic knee osteoarthritis (OA) ...
1. In this randomized controlled trial, once-weekly semaglutide led to significant weight loss compared to placebo over 68 weeks in ...
1. Isaclimab significantly improved disease activity at 150 mg and 600 mg doses. 2. Adverse events were comparable between cohorts ...
1. The use of rituximab, abatacept and Janus kinase inhibitors (JAKis) in individuals with rheumatoid arthritis (RA) was associated with ...
Estimated Effectiveness of Influenza Vaccines in Preventing Secondary Infections in Households 1. Influenza vaccination was associated with a reduced risk ...
1. Higher added sugar intake was associated with a greater risk of osteoarthritis, particularly in females, those with low body ...
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.